JP2007533683A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533683A5
JP2007533683A5 JP2007508805A JP2007508805A JP2007533683A5 JP 2007533683 A5 JP2007533683 A5 JP 2007533683A5 JP 2007508805 A JP2007508805 A JP 2007508805A JP 2007508805 A JP2007508805 A JP 2007508805A JP 2007533683 A5 JP2007533683 A5 JP 2007533683A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
treatment
group
composition according
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007508805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533683A (ja
Filing date
Publication date
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed filed Critical
Priority claimed from PCT/EP2005/004073 external-priority patent/WO2005102349A1/de
Publication of JP2007533683A publication Critical patent/JP2007533683A/ja
Publication of JP2007533683A5 publication Critical patent/JP2007533683A5/ja
Pending legal-status Critical Current

Links

JP2007508805A 2004-04-22 2005-04-18 呼吸器系疾患治療用のベンゾオキサジン含有医薬組成物 Pending JP2007533683A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07
PCT/EP2005/004073 WO2005102349A1 (de) 2004-04-22 2005-04-18 Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen

Publications (2)

Publication Number Publication Date
JP2007533683A JP2007533683A (ja) 2007-11-22
JP2007533683A5 true JP2007533683A5 (https=) 2008-10-23

Family

ID=34966478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007508805A Pending JP2007533683A (ja) 2004-04-22 2005-04-18 呼吸器系疾患治療用のベンゾオキサジン含有医薬組成物

Country Status (33)

Country Link
EP (2) EP1781298B1 (https=)
JP (1) JP2007533683A (https=)
KR (2) KR101287460B1 (https=)
AR (1) AR049262A1 (https=)
AT (1) ATE539754T1 (https=)
AU (1) AU2005235419B2 (https=)
BE (1) BE2015C065I2 (https=)
BR (1) BRPI0510080B8 (https=)
CA (1) CA2559699C (https=)
CY (3) CY1113890T1 (https=)
DK (2) DK2422786T3 (https=)
EA (1) EA013157B1 (https=)
EC (1) ECSP066947A (https=)
ES (2) ES2380370T3 (https=)
FI (1) FIC20170005I1 (https=)
FR (1) FR16C0029I2 (https=)
HU (1) HUS1500058I1 (https=)
IL (2) IL177685A (https=)
LT (1) LTC1781298I2 (https=)
LU (1) LU93066I2 (https=)
MY (1) MY148945A (https=)
NL (1) NL300779I2 (https=)
NO (2) NO337714B1 (https=)
NZ (1) NZ550797A (https=)
PE (1) PE20060462A1 (https=)
PL (2) PL2422786T3 (https=)
PT (2) PT1781298E (https=)
SG (1) SG152237A1 (https=)
SI (2) SI1781298T1 (https=)
TW (2) TWI372056B (https=)
UY (1) UY28861A1 (https=)
WO (1) WO2005102349A1 (https=)
ZA (1) ZA200606624B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
WO2006087316A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol
CN101208316B (zh) 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
US20070088030A1 (en) * 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
ATE529399T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
WO2007093608A1 (de) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
JP2010500318A (ja) * 2006-08-07 2010-01-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療用医薬組成物
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
WO2008049842A2 (en) * 2006-10-26 2008-05-02 Boehringer Ingelheim International Gmbh Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
CA2711582A1 (en) 2008-02-07 2009-08-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
CA2733153C (en) 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
CA2744655A1 (en) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Novel powdered crystalline medicines for inhalation
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
JP2015533131A (ja) * 2012-10-09 2015-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 咳を治療するためのベータ2−アドレナリン受容体作動薬

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3682457D1 (de) 1985-07-30 1991-12-19 Glaxo Group Ltd Geraet zur verabreichung von medikamenten an patienten.
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
BR0110331A (pt) 2000-04-27 2003-01-07 Boehringer Ingelheim Pharma Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos
CN100519558C (zh) 2000-10-12 2009-07-29 贝林格尔英格海姆法玛两合公司 结晶单水合物、其制备方法及其在制备药物组合中的用途
CZ302786B6 (cs) 2001-06-22 2011-11-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Krystalický bezvodý tiotropiumbromid, zpusob jeho výroby a jeho použití pro výrobu léciva pro lécbu asthmatu
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Similar Documents

Publication Publication Date Title
JP2007533683A5 (https=)
CA2427282C (en) Mixtures or organic compounds for the treatment of airway diseases
US20110135582A1 (en) Combination of medicaments for the treatment of respiratory diseases
ES2380370T3 (es) Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
TW200803840A (en) Organic compounds
JP2007500676A5 (https=)
CA2534120A1 (en) Medicaments for inhalation comprising anticholinergics and a betamimetic
CA2481268A1 (en) Medicaments comprising steroids and a novel anticholinergic
JP2009537585A (ja) 呼吸器疾患の治療のための新規医薬組成物
CA2534128A1 (en) Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
JP2009500310A5 (https=)
CA2650813A1 (en) New long-acting drug combinations for the treatment of respiratory diseases
JP2009526817A5 (https=)
CA2533792A1 (en) Medicaments for inhalation comprising steroids and fluorene carboxylic acid esters